Healthcare Roundup – Gilead not quite there with remdesivir nod in Europe, Chi-Med’s NDA for savolitinib accepted in China Life Science
Technology Roundup – Pair of U.S.-listed China ADRs to list shares in Hong Kong, Trump vs. Twitter war escalates further Technology
Aleafia Health Announces Closing of $14.95 Million Bought Deal Offering, Including Full Exercise of the Over-Allotment Option Technology
Technology Roundup – Trump signs executive order targeting social media, Cisco nearing $1B deal for ThousandEyes Technology
Healthcare Roundup – Roche launches new studies of Actemra + remdesivir, CVS Health to achieve 1,000 COVID-19 sample collection sites Life Science
EdiGene and Immunochina Announce Research and Development Collaboration to Develop Allogeneic CAR-T Therapy for Cancer Life Science
Healthcare Roundup – PhaseBio gets FDA OK for clinical trial of COVID-19 treatment, Moderna correction pressures COVID-19 vaccine developers Life Science
Technology Roundup – President threatens social media companies, Microsoft in talks to buy ~$2B stake in Jio Platforms Technology